CIE-10

CIE-10-código R22.7

You are here: Inicio > CIE-10 > R00-R99 > R20-R23 > R22

- CIE-10
Clasificación Internacional de Enfermedades
- R00-R99
Síntomas, signos y hallazgos anormales clínicos y de laboratorio, no clasificados en otra parte
- R20-R23
Síntomas y signos que involucran la piel y el tejido subcutáneo
- R22
Tumefacción, masa o prominencia de la piel y del tejido subcutáneo localizadas

R22.7

Tumefacción, masa o prominencia localizada en sitios múltiples

CIE-10 Сódigo R22.7 para Tumefacción, masa o prominencia localizada en sitios múltiples

ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us